Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed later-stage tilt small index

Abdominolpelvic Surgery: later-stage trial registry

A small indexed set (2 trials) with no open enrollment listed right now.

Corpus placement: #7,203 of 28,963 conditions by registered trial count.

2 US clinical trials · none currently recruiting · #7,203 of 28,963 conditions by registered trial count

Abdominolpelvic Surgery: 2 US clinical trials tracked, none currently recruiting.

Abdominolpelvic Surgery is the subject of 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 2 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Astellas Pharma Global Development, running 2 of these trials.

Closed portfolio, later-stage tilt

Abdominolpelvic Surgery has 2 registered US clinical trials; none are currently listed as recruiting, so most are completed or in follow-up.

0
open enrollment slots
0%
of trials open to enrollment
2
in Phase 3-4 (later-stage)
2
top sponsor: Astellas Pharma Global Development

Corpus placement: #7,203 of 28,963 conditions by registered trial count on ClinicalTrials.gov-derived indexes. Registry reference only, not medical advice.

Key findings

What ClinicalTrials.gov does not surface for Abdominolpelvic Surgery on its own pages , computed from the registry mirror as of 2026-07-11. Each line carries its own denominator so it can be quoted as it stands.

  1. Abdominolpelvic Surgery is recruiting below its size-band peers.

    0 of 2 indexed trials (0%) are open to enrollment, against a 46.5% average across 28,061 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 32

What this small Abdominolpelvic Surgery index shows

2 indexed studies, none listed as recruiting (0% open).

Phase mix: 2 late (III/IV) vs 0 early (I/II) (later-stage heavy).

Top sponsor: Astellas Pharma Global Development (2 trials), 0 others listed. 2 shown below, recruiting first. #7,203 of 28,963 conditions by registered trial count.

Why a small condition index still matters

Thin indexes still surface the registry rows that exist for this label. Counts stay small when ClinicalTrials.gov lists few studies under the condition string, not because this page omits rows. Verify any enrollment decision on ClinicalTrials.gov and with a clinician.

Frequently Asked Questions

How many clinical trials are there for Abdominolpelvic Surgery?

PlainTrial tracks 2 US clinical trials for Abdominolpelvic Surgery, of which 0 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Abdominolpelvic Surgery?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.